Emergent BioSolutions
EBS
#8033
Rank
A$0.53 B
Marketcap
A$10.28
Share price
-0.55%
Change (1 day)
18.27%
Change (1 year)

Emergent BioSolutions (EBS) - Total debt

Total debt on the balance sheet as of March 2026 : A$0.81 Billion

According to Emergent BioSolutions 's latest financial reports the company's total debt is A$0.81 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Emergent BioSolutions - Total debt on balance sheet (from 2004 to 2026)

Total debt by year

Year Total debt Change
2025-12-31A$0.85 B-19.95%
2024-12-31A$1.06 B-15.49%
2023-12-31A$1.26 B-38.88%
2022-12-31A$2.06 B78.08%
2021-12-31A$1.16 B1.96%
2020-12-31A$1.13 B-1.82%
2019-12-31A$1.15 B2.73%
2018-12-31A$1.12 B6422.81%
2017-12-31A$17.29 M-95.35%
2016-12-31A$0.37 B9.74%
2015-12-31A$0.33 B10.5%
2014-12-31A$0.30 B341.24%
2013-12-31A$69.5 M15.07%
2012-12-31A$60.4 M4.18%
2011-12-31A$57.98 M24.19%
2010-12-31A$46.68 M-36.18%
2009-12-31A$73.15 M-9.74%
2008-12-31A$81.05 M22.31%
2007-12-31A$66.26 M22.13%
2006-12-31A$54.25 M233.33%
2005-12-31A$16.27 M-2.11%
2004-12-31A$16.62 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Pfizer
PFE
A$90.71 B 11,010.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$69.91 B 8,462.94%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$35.92 B 4,299.65%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
A$0.47 M-99.94%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
A$0.76 M-99.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
A$2.71 M-99.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$24.06 B 2,847.52%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel